WOODHOUSE DAVID J (CEO and acting CFO) reported 1 transaction at NGM BIOPHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 1/18/2024ACC: 0001415889-24-001541
DirectorOfficer· CEO and acting CFO
Since Apr 2019
-13.03K
Net shares
Net seller
$17.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
13.03K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−13.03K
Price / share
$1.34
Trade value
$17.46K
% of position
9.0%
1/16/2024
144.85K→131.82K
Total
Net shares
−13.03K
Net value
-$17.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2024 | F · Tax Withholding | −13.03K | $1.34 | $17.46K | 9.0% | 144.85K | 131.82K |
| Total | −13.03K | -$17.46K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned80K
Total
80K indirect80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 80K | Indirect |
| Total | 80K | 80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported